0001209191-23-009882.txt : 20230215 0001209191-23-009882.hdr.sgml : 20230215 20230215190720 ACCESSION NUMBER: 0001209191-23-009882 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20230213 FILED AS OF DATE: 20230215 DATE AS OF CHANGE: 20230215 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Boyer David W. CENTRAL INDEX KEY: 0001909817 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-22705 FILM NUMBER: 23636746 MAIL ADDRESS: STREET 1: C/O NEUROCRINE BIOSCIENCES, INC. STREET 2: 12780 EL CAMINO REAL CITY: SAN DIEGO STATE: CA ZIP: 92130 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: NEUROCRINE BIOSCIENCES INC CENTRAL INDEX KEY: 0000914475 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] IRS NUMBER: 330525145 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 12780 EL CAMINO REAL CITY: SAN DIEGO STATE: CA ZIP: 92130 BUSINESS PHONE: (858) 617-7600 MAIL ADDRESS: STREET 1: 12780 EL CAMINO REAL CITY: SAN DIEGO STATE: CA ZIP: 92130 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2023-02-13 0 0000914475 NEUROCRINE BIOSCIENCES INC NBIX 0001909817 Boyer David W. 12780 EL CAMINO REAL SAN DIEGO CA 0 1 0 0 Chief Corp. Affairs Officer Stock Option 103.52 2023-02-13 4 A 0 45027 0.00 A 2033-02-13 Common Stock 45027 45027 D Restricted Stock Unit 2023-02-13 4 A 0 7245 0.00 A Common Stock 7245 7245 D Represents option of which 1/48th of the shares underlying the option becomes vested and exercisable on March 13, 2023 and an additional 1/48th of the shares underlying the option becomes vested and exercisable each month thereafter. Each Restricted Stock Unit represents a contingent right to receive one share of the Issuer Common Stock. The Restricted Stock Units will vest annually at 1/4 of the units vesting on each of February 13, 2024, February 13, 2025, February 13, 2026, and February 13, 2027. /s/ Darin Lippoldt, Attorney-in-Fact 2023-02-15